Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy DiaMedica Therapeutics stock
Learn how to easily invest in DiaMedica Therapeutics stock.
DiaMedica Therapeutics is a biotechnology business based in the US. DiaMedica Therapeutics shares (DMAC) are listed on the NASDAQ and all prices are listed in US Dollars. DiaMedica Therapeutics employs 14 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy DiaMedica Therapeutics stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – DMAC. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
DiaMedica Therapeutics stock price (NASDAQ: DMAC)Use our graph to track the performance of DMAC stocks over time.
DiaMedica Therapeutics shares at a glance
|Latest market close||$1.35|
|52-week range||$1.12 - $3.23|
|50-day moving average||$1.42|
|200-day moving average||$1.71|
|Wall St. target price||$8.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.59|
Buy DiaMedica Therapeutics stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy DiaMedica Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
DiaMedica Therapeutics price performance over time
|1 week (2023-01-26)||-6.25%|
|1 month (2022-12-30)||-14.56%|
|3 months (2022-11-02)||11.57%|
|6 months (2022-08-02)||-11.76%|
|1 year (2022-02-02)||-49.25%|
|2 years (2021-02-02)||-84.19%|
|3 years (2020-01-31)||4.3556|
|5 years (2018-02-02)||460.17%|
DiaMedica Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-19.36%|
|Return on equity TTM||-32.08%|
|Market capitalisation||$40.2 million|
TTM: trailing 12 months
DiaMedica Therapeutics share dividends
We're not expecting DiaMedica Therapeutics to pay a dividend over the next 12 months.
Have DiaMedica Therapeutics's shares ever split?
DiaMedica Therapeutics's shares were split on a 1:20 basis on 14 November 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your DiaMedica Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for DiaMedica Therapeutics shares which in turn could have impacted DiaMedica Therapeutics's share price.
DiaMedica Therapeutics share price volatility
Over the last 12 months, DiaMedica Therapeutics's shares have ranged in value from as little as $1.12 up to $3.225. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while DiaMedica Therapeutics's is 1.8172. This would suggest that DiaMedica Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
DiaMedica Therapeutics overview
DiaMedica Therapeutics Inc. , a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic stroke. It is also developing DM300 that is in pre-clinical stage for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016.
Frequently asked questionsWhat percentage of DiaMedica Therapeutics is owned by insiders or institutions?
Currently 27.089% of DiaMedica Therapeutics shares are held by insiders and 18.54% by institutions. How many people work for DiaMedica Therapeutics?
Latest data suggests 14 work at DiaMedica Therapeutics. When does the fiscal year end for DiaMedica Therapeutics?
DiaMedica Therapeutics's fiscal year ends in December. Where is DiaMedica Therapeutics based?
DiaMedica Therapeutics's address is: Two Carlson Parkway, Minneapolis, MN, United States, 55447 What is DiaMedica Therapeutics's ISIN number?
DiaMedica Therapeutics's international securities identification number is: CA25253X2077 What is DiaMedica Therapeutics's CUSIP number?
DiaMedica Therapeutics's Committee on Uniform Securities Identification Procedures number is: 25253X207
More guides on Finder
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert